Loading...
•
Mar 31, 2023
Select Medical Q1 2023 Earnings Report
Select Medical's financial performance improved in Q1 2023 with revenue and net income increasing.
Key Takeaways
Select Medical Holdings Corporation reported a 4.1% increase in revenue to $1,665.0 million for the first quarter ended March 31, 2023, compared to $1,599.5 million for the same quarter prior year. Net income increased 52.4% to $85.3 million, compared to $55.9 million for the same quarter, prior year.
Revenue increased by 4.1% to $1,665.0 million compared to the same quarter last year.
Net income increased by 52.4% to $85.3 million compared to the same quarter last year.
Earnings per common share increased 51.3% to $0.56 compared to the same quarter last year.
The Board of Directors declared a cash dividend of $0.125 per share.
Revenue by Segment
Forward Guidance
Select Medical reaffirms its 2023 business outlook for revenue, expecting consolidated revenue to be in the range of $6.5 billion to $6.7 billion. The company also expects Adjusted EBITDA to be in the range of $780.0 million to $820.0 million and fully diluted earnings per common share to be in the range of $1.75 to $1.99.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...